Market Fallers: AstraZeneca plc, Centrica, CRH PLC, International Consolidated Airlns Grp SA

Centrica Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Stock in AstraZeneca plc with EPIC code: LON:AZN has stepped down -1.36% or -89 points throughout today’s trading session so far. Investors did not seem confident throughout the trading session. The periods high has already touched 6468 dipping to 6419. The number of shares traded by this point in time totalled 525,821 with the daily average at 1,923,067. A 52 week share price high is 6634 about 107 points difference from the previous days close and putting the 52 week low at 5167 a difference of some 1360 points. AstraZeneca plc has a 20 day moving average of 6419 and the 50 day moving average at 6122.21. The current market cap is £84,452.60m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Monday, July 8, 2019 at 1:24:36 PM GMT with the stock price trading at 6438 GBX.

The trading price for Centrica PLC EPIC code: LON:CNA has moved down -1.79% or -1.58 points throughout today’s trading session so far. Sellers were not positive throughout the session. The high for the period has peaked at 88.18 dipping to 86.1. The volume total for shares traded up to this point was 8,752,780 with the daily average at 26,554,379. The 52 week high for the shares is 164.5 about 76.42 points in difference to the previous days close of business and a 52 week low sitting at 85.06 which is a variance of 3.02 points. Centrica PLC now has a 20 SMA of 90.96 and now the 50 day MA at 95.05. The market capitalisation is now £5,031.79m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Centrica PLC being recorded at Monday, July 8, 2019 at 1:24:29 PM GMT with the stock price trading at 86.5 GBX.

Stock in CRH PLC ticker lookup code: LON:CRH has decreased -1.38% or -37 points during today’s session so far. Investors did not seem confident throughout the trading session. The period high has peaked at 2670 and a low of 2640. The number of shares traded by this point in time totalled 299,462 whilst the daily average number of shares exchanged is just 1,687,588. The 52 week high price for the shares is 2751 which comes in at 67 points difference from the previous days close and putting the 52 week low at 1961 which is a difference of 723 points. CRH PLC now has a 20 SMA of 2593.3 and now the 50 day moving average now of 2562.08. Market capitalisation is now £21,194.53m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for CRH PLC being recorded at Monday, July 8, 2019 at 1:23:09 PM GMT with the stock price trading at 2647 GBX.

The share price for International Consolidated Airlns Grp SA company symbol: LON:IAG has moved down -1.62% or -7.4 points throughout today’s trading session so far. Investors aired on the negative side during this period. The periods high figure was 455.7 meanwhile the session low reached 447.6. The amount of shares exchanged has so far reached 2,414,595 whilst the average number of shares exchanged is 10,773,909. The 52 week high for the shares is 718.86 around 262.36 points difference from the previous days close and putting the 52 week low at 431.71 which is a difference of 24.79 points. International Consolidated Airlns Grp SA now has a 20 simple moving average of 466.37 and the 50 day moving average now of 486.42. This puts the market capitalisation now at £8,913.51m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for International Consolidated Airlns Grp SA being recorded at Monday, July 8, 2019 at 1:24:35 PM GMT with the stock price trading at 449.1 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
    AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.
    International Consolidated Airlines Group (LON:IAG) reports robust Q3 2024 results with a 15.4% rise in operating profit and a €350 million share buyback.
    AstraZeneca's Wainzua gains CHMP backing for EU approval in treating ATTRv-PN, marking a potential breakthrough with self-administered therapy.

      Search

      Search